Browse > Article

Effects of Gastrodia elata Blune Water Extract on RANKL-induced Osteoclast Differentiation  

Choi, Yun-Hong (Department of Anatomy & Institute for Environmental Science, Wonkwang University)
Song, Jeong-Hoon (Department of Plastic & Reconstructive Surgery, Wonkwang University)
Jang, Sung-Jo (Department of Neurosurgery, School of Medicine, Wonkwang University)
Kim, Jin-Kook (Department of Pathology, College of Oriental Medicine, Wonkwang University)
Choi, Min-Kyu (Department of Anatomy & Institute for Environmental Science, Wonkwang University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.24, no.5, 2010 , pp. 807-813 More about this Journal
Abstract
Impairment of balance between bone-resorbing osteoclasts and bone-forming osteoblasts result in bone disease. Especially, increased osteoclast formation and activity are responsible for bone diseases such as osteoporosis, rheumatoid arthritis, periodontal disease. Natural metabolites of plants have recently received much attention as an alternative tools for the development of novel therapeutic strategy. The aim of this study was to search the natural products to inhibit osteoclast differentiation and was to evaluate of its mechanism. Water extract of Gastrodia elata Blune significantly inhibited receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast differentiation in bone marrow macrophages (BMMs) in a dose dependent manner. However, water extract of Gastrodia elata Blune did not affect cytotoxicity when compared with control. The mRNA expression of c-Fos, NFATc1, and TRAP induced by RANKL was inhibited by water extract of Gastrodia elata Blune treatment. Also, water extract of Gastrodia elata Blune inhibited the protein expression of c-Fos and NFATc1 expression in BMMs treated with RANKL. Water extract of Gastrodia elata Blune suppressed the phosphorylation of p38 induced by RANKL. In general, RANKL considerably inhibited the expression level of Id2 and MafB known as negative regulators of osteoclastogenesis, but RANKL did not inhibit Id2 and MafB expression in BMMs when it was co-treated with Gastrodia elata Blune. Taken together, these results suggest that Gastrodia elata Blune may be a useful drug in the treatment of bone-related disease.
Keywords
Gastrodia elata Blune; bone; RANKL; osteoclast;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Liu, X.D., Zhu, Y.K., Umino, T., Spurzem, J.R., Romberger, D.J., Wang, H., Reed, E., Rennard, S.I. Cigarette smoke inhibits osteogenic differentiation and proliferation of human osteoprogenitor cells in monolayer and three-dimensional collagen gel culture. J. Lab. Clin. Med. 137: 208-219, 2001.   DOI   ScienceOn
2 Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H., Morita, I., Wagner, E.F., Mak, T.W., Serfling, E., Takayanagi, H. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202: 1261-1269, 2005.   DOI   ScienceOn
3 Sieweke, M., Tekotte, H., Frampton, J., Graf, T. MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell 85: 49-60, 1996.   DOI   ScienceOn
4 Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7: 292-304, 2007.   DOI   ScienceOn
5 Kwak, H.B., Kim, J.Y., Kim, K.J., Choi, M.K., Kim, J.J. Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss. Biol. Pharm. Bull. 32: 1193-1198, 2009.   DOI   ScienceOn
6 Chang, E.J., Ha, J., Huang, H., Kim, H.J., Woo, J.H., Lee, Y., Lee, Z.H., Kim, J.H., Kim, H.H. The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation. J. Cell Sci. 121: 2555-2564, 2008.   DOI   ScienceOn
7 Lee, J., Kim, K., Kim, J.H., Jin, H.M., Choi, H.K., Lee, S.H., Kook, H., Kim, K.K., Yokota, Y., Lee, S.Y., Choi, Y., Kim, N. Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood 107: 2686-2693, 2006.   DOI   ScienceOn
8 Melton, L.J. 3rd. Who has osteoporosis? A conflict between clinical and public health perspectives. J. Bone Miner. Res. 15: 2309-2314, 2000.   DOI   ScienceOn
9 Halasy-Nagy, J.M., Rodan, G.A., Reszka, A. Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Bone 29: 553-559, 2001.   DOI   ScienceOn
10 Dougall, W.C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M.E., Maliszewski, C.R., Armstrong, A., Shen, V., Bain, S., Cosman, D., Anderson, D., Morrissey, P.J., Peschon, J.J., Schuh, J. RANK is essential for osteoclast and lymph node development. Genes Dev. 13: 2412-2424, 1999.   DOI   ScienceOn
11 Matsuo, K., Galson, D.L., Zhao, C., Peng, L., Laplace, C., Wang, K.Z., Bachler, M.A., Amano, H., Aburatani, H., Ishikawa, H., Wagner, E.F. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-fos. J. Biol. Chem. 279: 26475-26480, 2004.   DOI   ScienceOn
12 Galibert, L., Tometsko, M.E., Anderson, D.M., Cosman, D., Dougall, W.C. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-$\kappa B$, a member of the TNFR superfamily. J. Biol. Chem. 273: 34120-34127, 1998.   DOI   ScienceOn
13 Tanaka, S., Miyazaki, T., Fukuda, A., Akiyama, T., Kadono, Y., Wakeyama, H., Kono, S., Hoshikawa, S., Nakamura, M., Ohshima, Y., Hikita, A., Nakamura, I., Nakamura, K. Molecular mechanism of the life and death of the osteoclast. Ann. N. Y. Acad. Sci. 1068: 180-186, 2006.   DOI   ScienceOn
14 Redlich, K., Hayer, S., Ricci, R., David, J.P., Tohidast-Akrad, M., Kollias, G., Steiner, G. Smolen, J.S. Wagner, E.F., Schett, G. Osteoclasts are essential for TNF-alpha-mediated joint destruction. J. Clin. Invest. 110: 1419-1427, 2002.   DOI
15 Lee, J.H., Jin, H., Shim, H.E., Kim, H.N., Ha, H., Lee, Z.H. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Mol. Pharmacol. 77: 17-25, 2010.   DOI   ScienceOn
16 Kim, K., Lee, S.H., Kim J.H., Choi, Y., Kim, N. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol. Endocrinol. 22: 176-185, 2008.   DOI
17 Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., et al: Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Developmental Cell, 3: 889-901, 2002.   DOI   ScienceOn
18 Kim, K., Kim, J., Lee, J., Kim, K., Lee, S., Kim, N. MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 109: 3253-3259, 2007.   DOI   ScienceOn
19 Merkel, K.D., Erdmann, J.M., McHugh, K.P., Abu-Amer, Y., Ross, F.P., Teitelbaum, S.L. Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am. J. Pathol. 154: 203-210, 1999.   DOI   ScienceOn
20 Lee, S.E., Woo, K.M., Kim, S.Y., Kim, H.M., Kwack, K., Lee, Z.H., Kim, H.H. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 1: 71-77, 2002.
21 Huang, H., Chang, E.J., Ryu, J., Lee, Z.H., Lee, Y., Kim, H.H. Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Biochem. Biophys. Res. Commun. 351: 99-105, 2006.   DOI   ScienceOn
22 Boyle, W.J., Simonet, W.S., Lacey, D.L. Osteoclast differentiation and activation. Nature, 423: 337-342, 2003.   DOI   ScienceOn
23 Yeung Him-Che. Handbook of Chinese herbs and formulas. Institute of Chinese Medicine, Los Angeles 1985.
24 Bown, D. Encyclopaedia of herbs and their uses. Dorling Kindersley, London. 1995.
25 Duke, J.A., Ayensu, E.S. Medicinal plants of China. 1985.
26 Huang, Z.L. Recent developments in pharmacological study and clinical application of Gastrodia elata in China. Zhong. Xi. Yi. Jie. He. Za. Zhi. 5: 251-254, 1985.
27 Teitelbaum, S.L., Ross, F.P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4: 638-649, 2003.   DOI   ScienceOn
28 Kwak, H.B., Yang, D., Ha, H., Lee, J.H., Kim, H.N., Woo, E.R., Lee, S., Kim, H.H., Lee, Z.H. Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1. Exp. Mol. Med. 38: 256-264, 2006.   DOI   ScienceOn
29 Kwak, H.B., Kim, J.H., Kim, D.J., Kwon, Y.M., Oh, J., Kim, Y.K. Effect of water extract of deer antler in osteoclast differentiation. Korean J. Oriental Physiology & pathology, 22: 891-895, 2008.   과학기술학회마을
30 Li, N., Wang, K.J., Chen, J.J., Zhou, J. Phenolic compounds from the rhizomes of Gastrodia elata. J. Asian Nat. Prod. Res. 9: 373-377, 2007.   DOI   ScienceOn
31 Khosla, S., Burr, D., Cauley, J., Dempster, D.W., Ebeling, P.R. Felsenberg, D., Gagel, R.F., Gilsanz, V., Guise, T., Koka, S., McCauley, L.K., McGowan, J., McKee, M.D., Mohla, S., Pendrys, D.G., Raisz, L.G., Ruggiero, S.L., Shafer, D.M., Shum, L., Silverman, S.L., Van Poznak, C.H., Watts, N., Woo, S.B., Shane, E. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J. Bone Miner. Res. 22: 1479-1491, 2007.   DOI   ScienceOn
32 Park, C.K., Kim, H.J., Kwak, H.B., Lee, T.H., Bang, M.H., Kim, C.M., Lee, Y., Chung, D.K., Baek, N.I., Kim, J., Lee, Z.H., Kim, H.H. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption. Int. Immunopharmacol. 7: 1507-1516, 2007.   DOI   ScienceOn
33 Oh, S., Kyung, T.W., Choi, H.S. Curcumin inhibits osteoclastogenesis by decreasing receptor activator of nuclear factor-kappaB ligand (RANKL) in bone marrow stromal cells. Mol. Cells 26: 486-489, 2008.